Gerstein HC - Search Results

1

Dual inhibition of the renin-angiotensin system in high-risk diabetes and risk for stroke and other outcomes: results of the ONTARGET trial.

Mann JF, Anderson C, Gao P, Gerstein HC, Boehm M, Rydén L, Sleight P, Teo KK, Yusuf S; ONTARGET investigators. Mann JF, et al. Among authors: gerstein hc. J Hypertens. 2013 Feb;31(2):414-21. doi: 10.1097/HJH.0b013e32835bf7b0. J Hypertens. 2013. PMID: 23249829 Clinical Trial.

2

Summary of randomized trials of angiotensin converting enzyme inhibitors.

Yusuf S, Lonn E, Bosch J, Gerstein H. Yusuf S, et al. Clin Exp Hypertens. 1999 Jul-Aug;21(5-6):835-45. doi: 10.3109/10641969909061013. Clin Exp Hypertens. 1999. PMID: 10423106 Free article. Review.

3

Ramipril and the development of diabetes.

Yusuf S, Gerstein H, Hoogwerf B, Pogue J, Bosch J, Wolffenbuttel BH, Zinman B; HOPE Study Investigators. Yusuf S, et al. JAMA. 2001 Oct 17;286(15):1882-5. doi: 10.1001/jama.286.15.1882. JAMA. 2001. PMID: 11597291 Clinical Trial.

4

Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy.

Lonn E, Yusuf S, Hoogwerf B, Pogue J, Yi Q, Zinman B, Bosch J, Dagenais G, Mann JF, Gerstein HC; HOPE Study; MICRO-HOPE Study. Lonn E, et al. Among authors: gerstein hc. Diabetes Care. 2002 Nov;25(11):1919-27. doi: 10.2337/diacare.25.11.1919. Diabetes Care. 2002. PMID: 12401733 Clinical Trial.

5

The relationship between dysglycemia and atherosclerosis in South Asian, Chinese, and European individuals in Canada: a randomly sampled cross-sectional study.

Gerstein HC, Anand S, Yi QL, Vuksan V, Lonn E, Teo K, Malmberg K, McQueen M, Yusuf S; SHARE Investigators. Gerstein HC, et al. Diabetes Care. 2003 Jan;26(1):144-9. doi: 10.2337/diacare.26.1.144. Diabetes Care. 2003. PMID: 12502671

6

Diagnostic strategies to detect glucose intolerance in a multiethnic population.

Anand SS, Razak F, Vuksan V, Gerstein HC, Malmberg K, Yi Q, Teo KK, Yusuf S. Anand SS, et al. Among authors: gerstein hc. Diabetes Care. 2003 Feb;26(2):290-6. doi: 10.2337/diacare.26.2.290. Diabetes Care. 2003. PMID: 12547851

7

Development of renal disease in people at high cardiovascular risk: results of the HOPE randomized study.

Mann JF, Gerstein HC, Yi QL, Lonn EM, Hoogwerf BJ, Rashkow A, Yusuf S. Mann JF, et al. Among authors: gerstein hc. J Am Soc Nephrol. 2003 Mar;14(3):641-7. doi: 10.1097/01.asn.0000051594.21922.99. J Am Soc Nephrol. 2003. PMID: 12595499 Clinical Trial.

8

Cardiovascular risk in patients with mild renal insufficiency.

Mann JF, Gerstein HC, Dulau-Florea I, Lonn E. Mann JF, et al. Among authors: gerstein hc. Kidney Int Suppl. 2003 May;(84):S192-6. doi: 10.1046/j.1523-1755.63.s84.27.x. Kidney Int Suppl. 2003. PMID: 12694342 Free article. Review.

9

Progression of renal insufficiency in type 2 diabetes with and without microalbuminuria: results of the Heart Outcomes and Prevention Evaluation (HOPE) randomized study.

Mann JF, Gerstein HC, Yi QL, Franke J, Lonn EM, Hoogwerf BJ, Rashkow A, Yusuf S; HOPE Investigators. Mann JF, et al. Among authors: gerstein hc. Am J Kidney Dis. 2003 Nov;42(5):936-42. doi: 10.1016/j.ajkd.2003.07.015. Am J Kidney Dis. 2003. PMID: 14582037 Clinical Trial.

10

Cardiovascular risk in patients with early renal insufficiency: implications for the use of ACE inhibitors.

Mann JF, Gerstein HC, Pogue J, Lonn E, Yusuf S. Mann JF, et al. Among authors: gerstein hc. Am J Cardiovasc Drugs. 2002;2(3):157-62. doi: 10.2165/00129784-200202030-00003. Am J Cardiovasc Drugs. 2002. PMID: 14727978 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

454 results

Search Page

Filters